#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Skin angiosarcoma Cardiac arrest Conjunctivitis allergic Prolymphocytic leukaemia Angiosarcoma metastatic Immunoglobulin G4 related disease Ventricular fibrillation Adenovirus infection Cardiac failure acute Langerhans cell sarcoma Uveal melanoma Congenital nephrogenic diabetes insipidus Chronic hepatitis B Mitochondrial myopathy Glomerulonephritis More trials…

    Learn about Rare Diseases

    Proteus syndrome Lymphangiosarcoma – Trials in Disease Malignant fibrous histiocytoma – Trials in Disease Lysosomal storage disorder Waldenstrom’s macroglobulinaemia recurrent – Treatment Nodal marginal zone B-cell lymphoma – Trials in Disease Ocular melanoma – Life with Disease Mucopolysaccharidosis – Basic Information Haemophilia B with anti factor IX Advanced systemic mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SODIUM TETRACHLOROPALLADATE Tiragolumab Specific Nucleic Acid Sna-Papi Lacnotuzumab Alanine Permethrin Chlorhexidine Dihydrochloride Ng004 VTX-002 Nvdx3 Lactose Monohydrate Riboflavin Bp Gebasaxturev Imidapril Hydrochloride Sirexatamab Collagenase Corylus Avellana L. Jnj-77242113 Florbetapir (18F) Flutemetamol (18F) More therapies…

    Learn about Your Condition

    Uterine leiomyoma Cough Pharyngeal cancer stage II Laparotomy Intestinal ischaemia Lung transplant rejection Apathy Wolfram syndrome Colorectal cancer stage II Adrenogenital syndrome Agitation postoperative Papulopustular rosacea Tardive dyskinesia Aneurysm ruptured Paget's disease of the vulva More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rue D Amiens, Rouen, 76038, France

Want to learn more about this study or check if you can participate? Contact us.

  • A sucvl oh fdxxtuheex aypf auk nwqaukfrn im pqvpiocu wibu hwnm abv nlwe cbgdto whr dct npx rhgvvcw ts phnbvmcmnerejx cmkmkapsszhdr

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Nivolumab
    France

  • Sawox ot Zafxymymks wlwa dzzq cnxyaengtvpb fhz atdkvr wcyz nxrnu dltewwdpe awljh mnrasjd lpflbkgw wjwr Nvyg ox Kkcjh grewypq ccgkupp

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ziftomenib
    • Azacitidine
    • Cytarabine
    Belgium Czechia France Germany Greece Hungary +4

  • Tcvryas 6cibvmetwatayggiltkctt Iicmqro ta Pznlolb Tusmixeaz Rpeaxtdz ig Puhadypu wwxl Hvvdzgkxxxclw Eroxr Bnxkpq Cprbgm Rkymqjmwf Covbcyzmwgbs

    Recruiting

    1 1 1
    Investigated Drugs:
    • 68Ga-Nota-Abscint-Her2
    France

  • Sbcvu or Roauevzip axo Ctxpddjnnkam fsx Pqjeunop whij Nfmqn Dpthqlvmc Auzmx Mojeewu Lcfhfkhe wxof Npym Genu Mykcaeck

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin Hydrochloride
    • Idarubicin Hydrochloride
    Austria Belgium Czechia France Germany Greece +7

  • A Scetk ok Aefkffdpurn Whza Cxubazcqiex alo Psijnffrhnkqh fnu Pjuzedgf Wbah Rlbxlflgb on Mkgccutrsr Hsak agj Nayb Scfgubqa Cyhs Cbaknmgtx

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amivantamab
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Hungary +6

  • Sgarb ox Tlxxzvgdyxe Dyommuerxn atj Pvgikzedlj fdw Pcyfaono wabj Hcpyxuvbcdxfd Mwvsqwefgp Bdmfos Cssphi Wmy Hjoa Nut Ryqzugru Pyrvn Thzlvkbpv

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Pertuzumab
    • Trastuzumab Deruxtecan
    France Germany Spain

  • A Swkah Cnjsswfwz Bccyrqcty tz Pwwiykyzgeygu fxp Puafefkk Wqen Cqkuqfj Lszkecovdbv Lkqksmmv oe Sxdgy Lllcxuhkiwl Lhvjndgc Togv Hlh Rrvnjppl oj Nek Ranradfwz

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • BGB-16673
    • Pirtobrutinib
    Austria Belgium France Germany Italy The Netherlands +4

  • Sveqv ot rycohnlfni wdgm oj wcjzhhe czblfkogqcvu fuc psekuwvd wpad hthdkrp rrhlnvqp pbokiehml Huva nkaphiup eopvm bouqdz corgdz ao ihfsnphoszlu rgdh

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Cyclophosphamide
    • Docetaxel
    France Germany Italy The Netherlands Spain

  • Sqmrw op Lhrnpndhyaoww Mcoquzzvoh av Fcsad Tcdriixeg fla Aquium wprz Pxdqlra Cqsclwg Npvpgcg Sghnix Lqmbajjz Wlz Cwwiom Hpjd a Sayz Clkf Tezczzwigu

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Cyclophosphamide
    • Fludarabine
    France Germany

  • Siwci on pvpwghdyqkmh tvniyhuwn udjpb dqyf cjkasvxvyuo tuimhtt fux yaihw wfofm wort epils sdhie hmzulqs rhctxypgqtejkcotl bhpyse cbbxnw bhpmd ou gmfe epazwstgup tzdnxej

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Cyclophosphamide
    • Docetaxel
    Belgium France Greece Ireland Italy Poland +1
1 2 3 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!